Our experience spans a diverse set of industries. That range gives us the perspective to read the nuances of your market—and the specific deal in front of you—and to tailor diligence to the risks and opportunities that drive value.
Providers, pharma and biotech, medical devices, and health-services businesses where reimbursement, payor mix, and regulation shape earnings quality.
Recurring-revenue models where retention, ARR bridges, and revenue recognition drive cash and earnings.
Capacity, inventory, and cost accounting in businesses where margin lives in the operational detail.
People-driven, project-based models where utilization, backlog, and revenue timing drive value.
Multi-channel businesses where unit economics, seasonality, and working capital cycles tell the story.
High-growth and subscription models where deferred revenue and capitalized costs warrant close scrutiny.
Capital-intensive assets where contract structures, long-cycle revenue, and reserves require careful analysis.
Specialty finance and fee-based businesses where credit, fee recognition, and balance-sheet quality are central.
Recurring revenue in software, reimbursement in healthcare, inventory and capacity in manufacturing—every industry carries its own definition of quality. We bring that context to the numbers so findings hold up in negotiation and beyond.
Wherever your deal sits, the discipline is the same: work from the source data, control for risk, and connect what we find to the decision in front of you.
Our methods travel across sectors. Tell us about the business and the transaction, and we will bring the right expertise to the table.